We Support Our Clients
ValueVector has competencies and experience to help clients operating in the global biopharmaceutical market in multiple ways
Navigating the business environment through the intricacies of diverse pricing, reimbursement and market access systems
Developing realistic forecasts, including the pricing, reimbursement and market access dimensions in the business outlook
Creating high quality Dossiers for HTA and Pricing and Reimbursement submissions
Designing and implementing product development and regulatory strategies aimed at optimizing pricing, reimbursement and market access opportunities
Successfully integrating pricing and reimbursement in overall marketing strategies, striking the optimal balance between all elements of the marketing mix
Designing pricing, reimbursement and market access scenarios for business development, licensing and other partnering initiatives
Since 2003, ValueVector has helped dozens of European and global clients, in the following therapeutic areas:
- Bacterial, fungal and viral infections
- Dermatology
- Oncology / oncohematology
- Radiopharmaceuticals
- Rare diseases / orphan drugs
- Rheumatology / autoimmune diseases
- Vaccines